NR1A Stock Overview
Provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 3/6 |
National Research Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$17.60 |
| 52 Week High | US$38.20 |
| 52 Week Low | US$16.10 |
| Beta | 0.53 |
| 11 Month Change | -1.68% |
| 3 Month Change | -7.37% |
| 1 Year Change | -52.94% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -50.28% |
Recent News & Updates
Recent updates
Shareholder Returns
| NR1A | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -3.3% | 0.1% | -1.5% |
| 1Y | -52.9% | 18.0% | 7.9% |
Return vs Industry: NR1A underperformed the German Healthcare industry which returned 19.2% over the past year.
Return vs Market: NR1A underperformed the German Market which returned 8.3% over the past year.
Price Volatility
| NR1A volatility | |
|---|---|
| NR1A Average Weekly Movement | 6.0% |
| Healthcare Industry Average Movement | 3.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: NR1A has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: NR1A's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 435 | Mike Hays | www.nrchealth.com |
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. The company also offers marketing solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools.
National Research Corporation Fundamentals Summary
| NR1A fundamental statistics | |
|---|---|
| Market cap | €426.82m |
| Earnings (TTM) | €25.72m |
| Revenue (TTM) | €136.93m |
16.0x
P/E Ratio3.0x
P/S RatioIs NR1A overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NR1A income statement (TTM) | |
|---|---|
| Revenue | US$144.16m |
| Cost of Revenue | US$56.38m |
| Gross Profit | US$87.78m |
| Other Expenses | US$60.70m |
| Earnings | US$27.08m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.15 |
| Gross Margin | 60.89% |
| Net Profit Margin | 18.78% |
| Debt/Equity Ratio | 154.9% |
How did NR1A perform over the long term?
See historical performance and comparisonDividends
2.6%
Current Dividend Yield43%
Payout RatioDoes NR1A pay a reliable dividends?
See NR1A dividend history and benchmarks| National Research dividend dates | |
|---|---|
| Ex Dividend Date | Dec 27 2024 |
| Dividend Pay Date | Jan 10 2025 |
| Days until Ex dividend | 37 days |
| Days until Dividend pay date | 51 days |
Does NR1A pay a reliable dividends?
See NR1A dividend history and benchmarks